SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the March 2024 quarter is pegged at Rs. 2199.38 millions, about 18.00% up against Rs. 1863.84 millions recorded during the year-ago period.Profit saw a slight increase of 18.12%to Rs. 320.80  millions from Rs. 271.58 millions.Operating Profit saw a handsome growth to 487.07 millions from 406.44 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2199.38 1863.84 18.00 6875.83 6167.34 11.49 6875.83 6167.34 11.49
Other Income 85.54 -1.74 -5016.09 137.86 43.20 219.12 137.86 43.20 219.12
PBIDT 487.07 406.44 19.84 1214.53 1269.82 -4.35 1214.53 1269.82 -4.35
Interest 20.56 5.94 246.13 58.94 24.14 144.16 58.94 24.14 144.16
PBDT 466.51 400.50 16.48 838.05 1245.68 -32.72 838.05 1245.68 -32.72
Depreciation 43.63 34.27 27.31 146.94 123.42 19.06 146.94 123.42 19.06
PBT 422.88 366.23 15.47 691.11 1122.26 -38.42 691.11 1122.26 -38.42
TAX 102.08 94.65 7.85 254.25 288.82 -11.97 254.25 288.82 -11.97
Deferred Tax 29.02 5.96 386.91 45.12 25.05 80.12 45.12 25.05 80.12
PAT 320.80 271.58 18.12 436.86 833.44 -47.58 436.86 833.44 -47.58
Equity 368.81 364.37 1.22 368.81 364.37 1.22 368.81 364.37 1.22
PBIDTM(%) 22.15 21.81 1.56 17.66 20.59 -14.21 17.66 20.59 -14.21

Acutaas Chemicals Share Price

2733.15 11.45 (0.42%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×